26.11.2020 15:04:12 CET | Demant A/S | Financial Calendar
Company announcementno 2020-13
26 November 2020
Financial calendar 2021
22 January
Deadline for submission of items for the agenda of the annual
general meeting*
19 January to 8 February
Quiet period prior to publication of Annual Report 2020
9 February
Annual Report 2020
5 March
Annual general meeting
13 April to 3 May
Quiet period prior to publication of Interim Management Statement
4 May
Interim Management Statement
16 and 17 June
Capital Markets Days
22 July to 11 August
Quiet period prior to publication of Interim Report 2021
12 August
Interim Report 2021
12 October to 1 November
Quiet period prior to publication of Interim Management Statement
2 November
Interim Management Statement
* Please note that if a shareholder would like to have a specific item included in the agenda for the general meeting on 5 March 2021, a written proposal must be submitted to the Board of Directors no later than six weeks prior to the annual general meeting, which means that proposals must reach the Board of Directors no later than 22 January 2021.
Further information:
Mathias Holten Møller, Head of Investor Relations
Christian Lange, Investor Relations Officer
Phone +45 3917 7300
www.demant.com
Contacts
Mathias Holten Møller, Director, Head of Investor Relations, +45 3913 8827, msmo@demant.com
Christian Lange, Investor Relations Officer, +45 3917 7300, chln@demant.com
About Demant A/S
Demant is a world-leading hearing healthcare group that offers solutions and services to help people with hearing loss connect with the world around them. In every aspect, from hearing devices, hearing implants, diagnostics to audio and video solutions and hearing care all over the world, Demant is active and engaged. Our innovative technologies and know-how help improve people's health and hear-ing. We create life-changing differences through hearing health.
Attachments
ritzau-2538-en.pdf
Download announcement as PDF.pdf
2020-13 Financial calendar 2021.pdf
Attachments
Original document
Permalink
Disclaimer
Demant A/S published this content on 26 November 2020 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 26 November 2020 14:48:02 UTC
Demant A/S is the world's 2nd leading producer of audio products. Net sales (excluding activities held for sale) break down by family of products as follows:
- tailor-made hearing aids (44.7%): hearing aid and audiphones sold under the Oticon, Bernafon, Philips and Sonic brands;
- hearing care products (40.5%): sold in clinics under the brands Audika, HearingLife, Hidden Hearing and Acústica Médica;
- diagnostic products (1116%): audiometers sold under the brands Maico, Interacoustics, amplivox, gsi, MedRx and audioscan;
- business communication solutions (3.7%).
Net sales (excluding activities held for sale) are distributed geographically as follows: Denmark (1.2%), France (9.9%), Europe (29.7%), the United States (34.1%), North America (7%), Asia (10.4%), Pacific (4.9%) and other (2.8%).
DEMANT A/S 
